Holen Sie sich die Stockscreener-App
0.7612
1.49%
0.0112
Handel nachbörslich:
.78
0.0188
+2.47%
Schlusskurs vom Vortag:
$0.75
Offen:
$0.7422
24-Stunden-Volumen:
35,037
Relative Volume:
0.22
Marktkapitalisierung:
$5.77M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-1.92M
KGV:
-1.9433
EPS:
-0.3917
Netto-Cashflow:
$-5.26M
1W Leistung:
+1.49%
1M Leistung:
-19.19%
6M Leistung:
-54.42%
1J Leistung:
-44.03%
1-Tages-Spanne:
$0.7401
$0.78
1-Wochen-Bereich:
$0.6913
$0.78
52-Wochen-Spanne:
$0.5306
$7.00
Mustang Bio Inc Stock (MBIO) Company Profile
Firmenname
Mustang Bio Inc
Sektor
Branche
Telefon
(781) 652-4500
Adresse
95 SAWYER RD, WALTHAM, NY
Compare MBIO vs VRTX, REGN, ARGX, ALNY, ONC
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
MBIO
Mustang Bio Inc
|
0.7612 | 5.68M | 0 | -1.92M | -5.26M | -0.3917 |
VRTX
Vertex Pharmaceuticals Inc
|
441.70 | 113.01B | 12.07B | 3.95B | 3.19B | 15.33 |
REGN
Regeneron Pharmaceuticals Inc
|
753.93 | 79.87B | 14.34B | 4.50B | 3.77B | 41.56 |
ARGX
Argen X Se Adr
|
840.87 | 51.51B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
333.39 | 45.29B | 3.71B | 313.75M | 465.38M | 2.2571 |
ONC
Beone Medicines Ltd Adr
|
319.94 | 34.41B | 5.36B | 287.73M | 924.18M | 2.5229 |
Mustang Bio Inc Stock (MBIO) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2021-05-18 | Eingeleitet | BTIG Research | Buy |
| 2020-10-02 | Eingeleitet | B. Riley FBR | Buy |
| 2019-11-20 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2019-08-13 | Eingeleitet | H.C. Wainwright | Buy |
| 2019-06-21 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2017-12-21 | Eingeleitet | Oppenheimer | Outperform |
Alle ansehen
Mustang Bio Inc Aktie (MBIO) Neueste Nachrichten
Stock Analysis: Does Mustang Bio Inc have a sustainable dividend2026 Highlights & Entry and Exit Point Strategies - baoquankhu1.vn
If You Invested $1,000 in Mustang Bio (MBIO) - Stock Titan
MBIO Should I Buy - Intellectia AI
BGMS Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
ERNA PE Ratio & Valuation, Is ERNA Overvalued - Intellectia AI
MBIO Stock Price, Quote & Chart | MUSTANG BIO INC (NASDAQ:MBIO) - ChartMill
Levels Update: Can Mustang Bio Inc sustain its profitabilityIndex Update & Capital Protection Trade Alerts - baoquankhu1.vn
Biotech Expansion Accelerating Viral Vector Manufacturing Market Insights 2026–2035 - Weekly Voice
Aug Weekly: Whats the profit margin of Mustang Bio Inc2026 Trends & Expert Approved Trade Ideas - baoquankhu1.vn
Europe Stocks: Research Stocks from Europe Stock Market - GuruFocus
SBFM PE Ratio & Valuation, Is SBFM Overvalued - Intellectia AI
T-cell Therapy Market is Expected to Grow USD 15.3 Billion by 2033 | At CAGR 15.11% - vocal.media
CYCN Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
Mustang Bio Inc stock faces prolonged decline amid biotech sector volatility and pipeline uncertaint - AD HOC NEWS
Mustang Bio, Inc. 2025 Annual Report: Clinical-Stage Biopharmaceutical Pipeline, Risks, and Regulatory Overview - Minichart
Glioma Pipeline Expands as 180+ Pharma Companies Advance - openPR.com
Mustang Bio 10-K: Net loss narrows to $(1.9)M; cash $17.3M, runway ≥12 months - TradingView
MBIO: 2025 net loss narrowed to $1.9M, cash rose to $17.3M, and liquidity outlook improved after restructuring - TradingView
Mustang Bio, Inc. Reports Earnings Results for the Full Year Ended December 31, 2025 - marketscreener.com
Mustang Bio (NASDAQ: MBIO) details GBM pipeline, Orphan status and cash - Stock Titan
Glioma Pipeline Expands As 180+ Pharma Companies Advance Several Novel Therapies, Finds Delveinsight Aivita Biomedical, Denovo Biopharma, Medicenna Therapeutics, Eli Lilly, Candel Therapeutics - Mena FN
Mustang Bio Inc Stock (ISIN: US62815P1003) Faces Analyst Sell Rating Amid Biotech Volatility - AD HOC NEWS
Mustang Bio Shares Surge After FDA Grants Orphan Drug Status - MSN
MBIO Soars on Orphan Drug Nod for Investigational Brain Cancer Therapy - MSN
Is Mustang Bio Inc. stock a safe buy before earnings2026 Institutional & Verified Technical Trade Signals - Naître et grandir
Buy Signal: Is Cheetah Mobile Inc. Depositary Receipt forming a double bottom2025 Geopolitical Influence & Comprehensive Market Scan Reports - baoquankhu1.vn
Is NKSH stock vulnerable to regulatory risksPortfolio Performance Report & Safe Entry Trade Reports - Naître et grandir
Sell Signal: Whats the profit margin of Mustang Bio IncDividend Hike & AI Based Trade Execution Alerts - baoquankhu1.vn
MBIO PE Ratio & Valuation, Is MBIO Overvalued - Intellectia AI
Short Interest in Mustang Bio, Inc. (NASDAQ:MBIO) Rises By 405.2% - Defense World
MBIO Stock News Today | Earnings, Events & Price Alerts - Intellectia AI
Critical Contrast: Mustang Bio (NASDAQ:MBIO) & AstraZeneca (NASDAQ:AZN) - Defense World
Market Overview: Is LAND still a buy after recent gainsWeekly Trading Summary & Weekly Breakout Opportunity Watchlist - baoquankhu1.vn
MBIO Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
MSN Money - MSN
Will CWAN stock boost dividends further2025 Trade Ideas & AI Powered Buy/Sell Recommendations - mfd.ru
Is ARQQ benefiting from interest rate changesStop Loss & Free Daily Entry Point Trade Alerts - mfd.ru
Glioblastoma Pipeline 2025: Therapies Under Investigation, Clinical Trials Milestones, and FDA Approvals by DelveInsight | InovioPharma, Pfizer, Roche, ACADIA Pharma, BioNTech, Oncotelic Therapeutics - Barchart.com
US Market Wrap: Will Akoya Biosciences Inc benefit from green energy policiesTreasury Yields & Consistent Growth Stock Picks - baoquankhu1.vn
Glioma Clinical Trial Pipeline Gains Momentum: 180+ Companies Lead the Charge in Pioneering New Treatments | DelveInsight - Barchart.com
Aug Setups: Will SHRFP benefit from government policyMarket Growth Review & Growth Oriented Trading Recommendations - baoquankhu1.vn
12 Health Care Stocks Moving In Friday's Pre-Market Session - Benzinga
How cyclical is Mustang Bio Inc.’s revenue streamMarket Volume Summary & Daily Risk Controlled Trade Plans - mfd.ru
Aug Rallies: Does Mustang Bio Inc have a sustainable dividendEntry Point & Reliable Price Breakout Alerts - baoquankhu1.vn
MACD Signal: What is OneMain Holdings Incs debt to equity ratioWeekly Profit Summary & Momentum Based Trading Ideas - baoquankhu1.vn
Mustang Bio sells assets and ends lease with AbbVie - MSN
Can Mustang Bio Inc. sustain its profitability2025 Sector Review & Daily Chart Pattern Signals - mfd.ru
Cellares and City of Hope to Automate Manufacturing of Solid Tumor CAR T Cell Therapy - The Medicine Maker
CEO Moves: Can Mustang Bio Inc sustain its profitabilityJuly 2025 PostEarnings & Accurate Intraday Trade Tips - baoquankhu1.vn
Aug Technicals: Does Mustang Bio Inc have pricing power2025 Macro Impact & Safe Swing Trade Setup Alerts - baoquankhu1.vn
Returns Recap: How is ARRY managing supply chain issues2025 Historical Comparison & Safe Entry Momentum Tips - baoquankhu1.vn
Finanzdaten der Mustang Bio Inc-Aktie (MBIO)
Umsatz
Nettogewinn
Free Cashflow
ENV
2.69%
0.25%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):